Open Access
Nature Communications, volume 10, issue 1, publication number 524
The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
Liu Yang
1, 2
,
Gao Yamin
2, 3
,
Liu Jianxiong
4
,
Tan Yaoju
4
,
Liu Zhiyong
2
,
Chhotaray Chiranjibi
2, 3
,
Jiang Huofeng
2, 5
,
Lu Zhili
2
,
Gift Chiwala
2, 3
,
Wang Shuai
2, 3
,
Makafe Gaelle
2, 3
,
Islam Md Mahmudul
2, 3
,
Hameed H M Adnan
2, 3
,
Cai Xingshan
4
,
Wang Changwei
2
,
Li Xinjie
4
,
Tan Shouyong
4
,
Zhang Tianyu
2, 3
2
State Key Laboratory of Respiratory Disease, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (GRMH-GDL), Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, China
|
4
State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, China
|
5
School of life Sciences, University of Science and Technology of China, Hefei, China
|
Publication type: Journal Article
Publication date: 2019-01-31
Journal:
Nature Communications
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 16.6
ISSN: 20411723
PubMed ID:
30705268
General Chemistry
General Biochemistry, Genetics and Molecular Biology
General Physics and Astronomy
Abstract
Buruli ulcer (BU) is an emerging infectious disease that causes disfiguring skin ulcers. The causative agent, Mycobacterium ulcerans, secretes toxin called mycolactone that triggers inflammation and immunopathology. Existing treatments are lengthy and consist of drugs developed for tuberculosis. Here, we report that a pyrazolo[1,5-a]pyridine-3-carboxamide, TB47, is highly bactericidal against M. ulcerans both in vitro and in vivo. In the validated mouse model of BU, TB47 alone reduces M. ulcerans burden in mouse footpads by more than 2.5 log10 CFU compared to the standard BU treatment regimen recommended by the WHO. We show that mutations of ubiquinol-cytochrome C reductase cytochrome subunit B confer resistance to TB47 and the dissimilarity of CydABs from different mycobacteria may account for their differences in susceptibility to TB47. TB47 is highly potent against M. ulcerans and possesses desirable pharmacological attributes and low toxicity that warrant further assessment of this agent for treatment of BU.Combination therapy for Buruli ulcer (BU) is suboptimal. Here, Liu et al. show that the candidate drug TB47 has potent bactericidal activity against Mycobacterium ulcerans in vitro and in a mouse model, which underscores its potential for shortening the course of BU and treating other mycobacterial diseases.
Citations by journals
1
2
3
|
|
Journal of Medicinal Chemistry
|
Journal of Medicinal Chemistry
3 publications, 7.32%
|
Antimicrobial Agents and Chemotherapy
|
Antimicrobial Agents and Chemotherapy
3 publications, 7.32%
|
Pharmaceuticals
|
Pharmaceuticals
2 publications, 4.88%
|
Progress in Biophysics and Molecular Biology
|
Progress in Biophysics and Molecular Biology
2 publications, 4.88%
|
Biosensors and Bioelectronics
|
Biosensors and Bioelectronics
2 publications, 4.88%
|
ACS Infectious Diseases
|
ACS Infectious Diseases
2 publications, 4.88%
|
Journal of Natural Products
|
Journal of Natural Products
2 publications, 4.88%
|
Frontiers in Cellular and Infection Microbiology
|
Frontiers in Cellular and Infection Microbiology
1 publication, 2.44%
|
Frontiers in Chemistry
|
Frontiers in Chemistry
1 publication, 2.44%
|
Journal of Infection and Public Health
|
Journal of Infection and Public Health
1 publication, 2.44%
|
PLoS ONE
|
PLoS ONE
1 publication, 2.44%
|
Cell Chemical Biology
|
Cell Chemical Biology
1 publication, 2.44%
|
Biomedicine and Pharmacotherapy
|
Biomedicine and Pharmacotherapy
1 publication, 2.44%
|
Acta Pharmaceutica Sinica B
|
Acta Pharmaceutica Sinica B
1 publication, 2.44%
|
Journal of Controlled Release
|
Journal of Controlled Release
1 publication, 2.44%
|
Immunological Reviews
|
Immunological Reviews
1 publication, 2.44%
|
Journal of Organic Chemistry
|
Journal of Organic Chemistry
1 publication, 2.44%
|
New Journal of Chemistry
|
New Journal of Chemistry
1 publication, 2.44%
|
Chemical Communications
|
Chemical Communications
1 publication, 2.44%
|
RSC Advances
|
RSC Advances
1 publication, 2.44%
|
Expert Review of Clinical Pharmacology
|
Expert Review of Clinical Pharmacology
1 publication, 2.44%
|
Drug Design, Development and Therapy
|
Drug Design, Development and Therapy
1 publication, 2.44%
|
Microbiology spectrum
|
Microbiology spectrum
1 publication, 2.44%
|
Proceedings of the National Academy of Sciences of the United States of America
|
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 2.44%
|
eLife
|
eLife
1 publication, 2.44%
|
Bioorganic and Medicinal Chemistry Letters
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 2.44%
|
European Journal of Medicinal Chemistry
|
European Journal of Medicinal Chemistry
1 publication, 2.44%
|
Therapeutic Advances in Infectious Disease
|
Therapeutic Advances in Infectious Disease
1 publication, 2.44%
|
Letters in Drug Design and Discovery
|
Letters in Drug Design and Discovery
1 publication, 2.44%
|
1
2
3
|
Citations by publishers
2
4
6
8
10
12
|
|
Elsevier
|
Elsevier
11 publications, 26.83%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
8 publications, 19.51%
|
American Society for Microbiology
|
American Society for Microbiology
4 publications, 9.76%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
3 publications, 7.32%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 4.88%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
2 publications, 4.88%
|
Cold Spring Harbor Laboratory
|
Cold Spring Harbor Laboratory
2 publications, 4.88%
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
1 publication, 2.44%
|
Wiley
|
Wiley
1 publication, 2.44%
|
Taylor & Francis
|
Taylor & Francis
1 publication, 2.44%
|
Dove Medical Press
|
Dove Medical Press
1 publication, 2.44%
|
Proceedings of the National Academy of Sciences (PNAS)
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 2.44%
|
eLife Sciences Publications
|
eLife Sciences Publications
1 publication, 2.44%
|
SAGE
|
SAGE
1 publication, 2.44%
|
Bentham Science
|
Bentham Science
1 publication, 2.44%
|
2
4
6
8
10
12
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2019,2020,2021,2022,2023,2024],"ids":[0,0,0,0,0,0],"codes":[0,0,0,0,0,0],"imageUrls":["","","","","",""],"datasets":[{"label":"Citations number","data":[1,11,10,7,5,7],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["2.44","26.83","24.39","17.07","12.2","17.07"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Journal of Medicinal Chemistry","Antimicrobial Agents and Chemotherapy","Pharmaceuticals","Progress in Biophysics and Molecular Biology","Biosensors and Bioelectronics","ACS Infectious Diseases","Journal of Natural Products","Frontiers in Cellular and Infection Microbiology","Frontiers in Chemistry","Journal of Infection and Public Health","PLoS ONE","Cell Chemical Biology","Biomedicine and Pharmacotherapy","Acta Pharmaceutica Sinica B","Journal of Controlled Release","Immunological Reviews","Journal of Organic Chemistry","New Journal of Chemistry","Chemical Communications","RSC Advances","Expert Review of Clinical Pharmacology","Drug Design, Development and Therapy","Microbiology spectrum","Proceedings of the National Academy of Sciences of the United States of America","eLife","Bioorganic and Medicinal Chemistry Letters","European Journal of Medicinal Chemistry","Therapeutic Advances in Infectious Disease","Letters in Drug Design and Discovery"],"ids":[3673,17567,1203,2109,18799,7781,16163,21709,6407,19262,24963,4893,23951,11233,14351,17904,8697,1404,9073,3100,19376,24856,17855,306,24138,8828,8171,26891,7124],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/mxFdPe9qujsfvfYfcN0QOclAiYORFb0xrRlwV8gs_medium.webp","\/storage\/images\/resized\/eIZgkq1MRZyJ3hBkdupnUUv7wgB6zCl9D99SlPN5_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp"],"datasets":[{"label":"","data":[3,3,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[7.32,7.32,4.88,4.88,4.88,4.88,4.88,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","American Chemical Society (ACS)","American Society for Microbiology","Royal Society of Chemistry (RSC)","Multidisciplinary Digital Publishing Institute (MDPI)","Frontiers Media S.A.","Cold Spring Harbor Laboratory","Public Library of Science (PLoS)","Wiley","Taylor & Francis","Dove Medical Press","Proceedings of the National Academy of Sciences (PNAS)","eLife Sciences Publications","SAGE","Bentham Science"],"ids":[17,40,142,123,202,208,6909,344,11,18,417,162,6627,31,39],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/hg4jJjT8wVGtHstBCc0zk465Mg9pLx3G4odCDOqE_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/mxFdPe9qujsfvfYfcN0QOclAiYORFb0xrRlwV8gs_medium.webp","\/storage\/images\/resized\/eIZgkq1MRZyJ3hBkdupnUUv7wgB6zCl9D99SlPN5_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp"],"datasets":[{"label":"","data":[11,8,4,3,2,2,2,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[26.83,19.51,9.76,7.32,4.88,4.88,4.88,2.44,2.44,2.44,2.44,2.44,2.44,2.44,2.44],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Liu Y. et al. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model // Nature Communications. 2019. Vol. 10. No. 1. 524
GOST all authors (up to 50)
Copy
Liu Y., Gao Y., Liu J., Tan Y., Liu Z., Chhotaray C., Jiang H., Lu Z., Gift C., Wang S., Makafe G., Islam M. M., Hameed H. M. A., Cai X., Wang C., Li X., Tan S., Zhang T. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model // Nature Communications. 2019. Vol. 10. No. 1. 524
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/s41467-019-08464-y
UR - https://doi.org/10.1038%2Fs41467-019-08464-y
TI - The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
T2 - Nature Communications
AU - Liu, Yang
AU - Gao, Yamin
AU - Liu, Jianxiong
AU - Tan, Yaoju
AU - Liu, Zhiyong
AU - Chhotaray, Chiranjibi
AU - Jiang, Huofeng
AU - Lu, Zhili
AU - Gift, Chiwala
AU - Wang, Shuai
AU - Makafe, Gaelle
AU - Islam, Md Mahmudul
AU - Hameed, H M Adnan
AU - Cai, Xingshan
AU - Wang, Changwei
AU - Li, Xinjie
AU - Tan, Shouyong
AU - Zhang, Tianyu
PY - 2019
DA - 2019/01/31 00:00:00
PB - Springer Nature
IS - 1
VL - 10
PMID - 30705268
SN - 2041-1723
ER -
Cite this
BibTex
Copy
@article{2019_Liu,
author = {Yang Liu and Yamin Gao and Jianxiong Liu and Yaoju Tan and Zhiyong Liu and Chiranjibi Chhotaray and Huofeng Jiang and Zhili Lu and Chiwala Gift and Shuai Wang and Gaelle Makafe and Md Mahmudul Islam and H M Adnan Hameed and Xingshan Cai and Changwei Wang and Xinjie Li and Shouyong Tan and Tianyu Zhang},
title = {The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model},
journal = {Nature Communications},
year = {2019},
volume = {10},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1038%2Fs41467-019-08464-y},
number = {1},
doi = {10.1038/s41467-019-08464-y}
}